Sulforaphane: from chemoprevention to pancreatic cancer treatment?
Lampe
Johanna W
JW
Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, 1100 Fairview Ave N, M4-B402, PO Box 19024, Seattle, WA 98109, USA. jlampe@fhcrc.org
D016588:Anticarcinogenic Agents / Q000627:therapeutic use*; D017209:Apoptosis / Q000187:drug effects; D015972:Gene Expression Regulation, Neoplastic / Q000187:drug effects; D006801:Humans; D017879:Isothiocyanates; D016328:NF-kappa B / Q000378:metabolism*; D010190:Pancreatic Neoplasms / Q000517:prevention & control*; D013454:Sulfoxides; D013861:Thiocyanates / Q000627:therapeutic use*
D016588:Anticarcinogenic Agents; D017879:Isothiocyanates; D016328:NF-kappa B; D013454:Sulfoxides; D013861:Thiocyanates; C016766:sulforaphane